| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |